英科医疗
(300677)
| 流通市值：115.83亿 | | | 总市值：160.03亿 |
| 流通股本：4.69亿 | | | 总股本：6.48亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 6,918,724,492 | 5,041,996,590 | 3,294,949,978 | 1,572,919,050 |
| 营业收入 | 6,918,724,492 | 5,041,996,590 | 3,294,949,978 | 1,572,919,050 |
| 二、营业总成本 | 6,753,560,264 | 4,798,966,381 | 3,004,219,296 | 1,744,533,179 |
| 营业成本 | 5,971,022,961 | 4,403,293,331 | 2,943,065,479 | 1,452,066,171 |
| 税金及附加 | 67,291,682 | 46,389,304 | 32,278,690 | 16,803,103 |
| 销售费用 | 251,802,363 | 178,319,470 | 109,034,323 | 50,854,622 |
| 管理费用 | 486,505,810 | 379,063,004 | 243,219,325 | 117,335,665 |
| 研发费用 | 283,373,145 | 201,276,033 | 133,712,234 | 63,880,401 |
| 财务费用 | -306,435,697 | -409,374,761 | -457,090,755 | 43,593,217 |
| 其中:利息费用 | 127,741,395 | 83,168,700 | 44,667,937 | 15,015,622 |
| 其中:利息收入 | 308,711,986 | 210,397,707 | 131,992,581 | 68,913,002 |
| 加:公允价值变动收益 | 175,567,235 | 123,039,009 | 88,759,073 | -4,250,033 |
| 加:投资收益 | 87,446,122 | 78,201,382 | 51,865,345 | 16,104,156 |
| 资产处置收益 | 213,378 | 44,432 | 44,432 | 16,043 |
| 资产减值损失(新) | -5,349,202 | -681,394 | -681,394 | - |
| 信用减值损失(新) | -24,364,955 | -13,655,793 | -11,266,843 | -4,318,517 |
| 其他收益 | 40,313,542 | 39,152,854 | 24,901,615 | 13,964,426 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 438,990,348 | 469,130,699 | 444,352,910 | -150,098,054 |
| 加:营业外收入 | 38,341,123 | 1,663,242 | 1,050,726 | 588,495 |
| 减:营业外支出 | 34,513,221 | 29,424,922 | 20,784,296 | 5,533,675 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 442,818,250 | 441,369,019 | 424,619,340 | -155,043,234 |
| 减:所得税费用 | 54,753,445 | 104,112,275 | 120,132,905 | -8,274,341 |
| 六、净利润 | 388,064,805 | 337,256,744 | 304,486,435 | -146,768,893 |
| 持续经营净利润 | 388,064,805 | 337,256,744 | 304,486,435 | -146,768,893 |
| 归属于母公司股东的净利润 | 382,997,569 | 330,851,410 | 293,155,962 | -153,056,715 |
| 少数股东损益 | 5,067,236 | 6,405,334 | 11,330,473 | 6,287,822 |
| (一)基本每股收益 | 0.58 | 0.5 | 0.44 | -0.23 |
| (二)稀释每股收益 | 0.58 | 0.5 | 0.44 | -0.23 |
| 八、其他综合收益 | -11,210,967 | -21,577,057 | -23,897,654 | -5,317,419 |
| 归属于母公司股东的其他综合收益 | -11,210,967 | -21,577,057 | -23,897,654 | -5,317,419 |
| 九、综合收益总额 | 376,853,838 | 315,679,687 | 280,588,781 | -152,086,312 |
| 归属于母公司股东的综合收益总额 | 371,786,602 | 309,274,353 | 269,258,308 | -158,374,134 |
| 归属于少数股东的综合收益总额 | 5,067,236 | 6,405,334 | 11,330,473 | 6,287,822 |
| 公告日期 | 2024-04-24 | 2023-10-28 | 2023-08-30 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | | | |